Related Experiment Video
Updated: Jul 14, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Factors Predictive of Treatment Success in CT-Guided Fibrin Occlusion of CSF-Venous Fistulas: A Multicenter
Andrew L Callen1, Lalani Carlton Jones2, Vincent M Timpone3
1From the Department of Radiology (A.L.C., V.M.T.), Neuroradiology Section, University of Colorado Anschutz Medical Campus, Aurora, Colorado andrew.callen@cuanschutz.edu.
Insights
CT-guided fibrin occlusion for cerebrospinal fluid (CSF)-to-venous fistulas shows promising results. Successful treatment correlates with precise injectate placement matching fistula drainage and early intervention for spontaneous intracranial hypotension.
Area of Science:
- Neurosurgery
- Interventional Radiology
- Neurology
Background:
- Spontaneous intracranial hypotension is often caused by cerebrospinal fluid (CSF)-to-venous fistulas.
- CT-guided fibrin occlusion is a minimally invasive treatment, but its multi-institutional reproducibility is not well-established.
Purpose of the Study:
- To evaluate the clinical and radiologic outcomes of CT-guided fibrin occlusion for CSF-to-venous fistulas across multiple institutions.
- To investigate correlations between cure rates, fibrin injectate spread, and drainage patterns.
Main Methods:
- Retrospective analysis of 119 patients treated with CT-guided fibrin glue from 6 institutions (2020-2023).
- Evaluation of patient data, procedural details, injectate spread, and drainage patterns.
- Clinical improvement assessed via medical records served as the primary outcome.
Main Results:
- Complete clinical improvement in 59.7% of patients, partial improvement in 34.5%, and no improvement in 5.9% at a mean follow-up of 5.0 months.
- Complications occurred in 4% of cases.
- Significant associations found between clinical improvement and matching injectate spread with fistula drainage (P = .0089) and shorter symptom duration (P < .001).
Conclusions:
- CT-guided fibrin occlusion is effective across institutions when injectate spread matches the CSF-to-venous fistula drainage pattern.
- Early intervention and accurate injectate placement are crucial for successful treatment of spontaneous intracranial hypotension.
Background And Purpose:
CSF-to-venous fistulas contribute to spontaneous intracranial hypotension. CT-guided fibrin occlusion has been described as a minimally invasive treatment strategy; however, its reproducibility across different institutions remains unclear. This multi-institution study evaluated the clinical and radiologic outcomes of CT-guided fibrin occlusion, hypothesizing a correlation among cure rates, fibrin injectate spread, and drainage patterns.
Materials And Methods:
A retrospective evaluation was conducted on CT-guided fibrin glue treatment in patients with CSF-to-venous fistulas from 6 US and UK institutions from 2020 to 2023. Patient information, procedural characteristics, and injectate spread and drainage patterns were examined. Clinical improvement assessed through medical records served as the primary outcome.
Results:
Of 119 patients at a mean follow-up of 5.0 months, fibrin occlusion resulted in complete clinical improvement in 59.7%, partial improvement in 34.5%, and no improvement in 5.9% of patients. Complications were reported in 4% of cases. Significant associations were observed between clinical improvement and concordant injectate spread with the fistula drainage pattern (P = .0089) and pretreatment symptom duration (P < .001). No associations were found between clinical improvement and cyst puncture, intravascular extension, rebound headache, body mass index, age, or number of treatment attempts.
Conclusions:
Fibrin occlusion performed across various institutions shows cure when associated with injectate spread matching the CVF drainage pattern and shorter pretreatment symptom duration, emphasizing the importance of accurate injectate placement and early intervention.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

